Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy.

Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, Baughman KL, Kasper EK.

N Engl J Med. 2000 Apr 13;342(15):1077-84.

2.

Predictors of mortality in patients with dilated cardiomyopathy: relevance of chagas disease as an etiological factor.

Pereira Nunes Mdo C, Barbosa MM, Ribeiro AL, Amorim Fenelon LM, Rocha MO.

Rev Esp Cardiol. 2010 Jul;63(7):788-97. English, Spanish.

3.

Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

Ponikowski P, Anker SD, Chua TP, Szelemej R, Piepoli M, Adamopoulos S, Webb-Peploe K, Harrington D, Banasiak W, Wrabec K, Coats AJ.

Am J Cardiol. 1997 Jun 15;79(12):1645-50.

PMID:
9202356
4.
5.

Effect of myocardial ischemia during dobutamine stress echocardiography on cardiac mortality in patients with heart failure secondary to ischemic cardiomyopathy.

Elhendy A, Sozzi F, van Domburg RT, Bax JJ, Schinkel AF, Roelandt JR, Poldermans D.

Am J Cardiol. 2005 Aug 15;96(4):469-73.

PMID:
16098295
6.

Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction.

Dries DL, Sweitzer NK, Drazner MH, Stevenson LW, Gersh BJ.

J Am Coll Cardiol. 2001 Aug;38(2):421-8.

7.

The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial.

Domanski M, Krause-Steinrauf H, Deedwania P, Follmann D, Ghali JK, Gilbert E, Haffner S, Katz R, Lindenfeld J, Lowes BD, Martin W, McGrew F, Bristow MR; BEST Investigators.

J Am Coll Cardiol. 2003 Sep 3;42(5):914-22.

8.

Pulmonary hypertension and risk of death in cardiomyopathy: patients with myocarditis are at higher risk.

Cappola TP, Felker GM, Kao WH, Hare JM, Baughman KL, Kasper EK.

Circulation. 2002 Apr 9;105(14):1663-8.

9.

Sex-based differences in the effect of digoxin for the treatment of heart failure.

Rathore SS, Wang Y, Krumholz HM.

N Engl J Med. 2002 Oct 31;347(18):1403-11.

10.

Poor prognosis of Japanese patients with chronic heart failure following myocardial infarction--comparison with nonischemic cardiomyopathy.

Shiba N, Watanabe J, Shinozaki T, Koseki Y, Sakuma M, Kagaya Y, Shirato K.

Circ J. 2005 Feb;69(2):143-9.

11.

Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study.

Salerno-Uriarte JA, De Ferrari GM, Klersy C, Pedretti RF, Tritto M, Sallusti L, Libero L, Pettinati G, Molon G, Curnis A, Occhetta E, Morandi F, Ferrero P, Accardi F; ALPHA Study Group Investigators.

J Am Coll Cardiol. 2007 Nov 6;50(19):1896-904. Epub 2007 Oct 22.

12.

Incidence and prognosis of syncope.

Soteriades ES, Evans JC, Larson MG, Chen MH, Chen L, Benjamin EJ, Levy D.

N Engl J Med. 2002 Sep 19;347(12):878-85.

13.

Prognostic value of QT interval parameters for mortality risk stratification in Chagas' disease: results of a long-term follow-up study.

Salles G, Xavier S, Sousa A, Hasslocher-Moreno A, Cardoso C.

Circulation. 2003 Jul 22;108(3):305-12. Epub 2003 Jun 30.

14.

Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy.

Bart BA, Shaw LK, McCants CB Jr, Fortin DF, Lee KL, Califf RM, O'Connor CM.

J Am Coll Cardiol. 1997 Oct;30(4):1002-8.

15.

Prognostic value of heart rate variability during long-term follow-up in patients with mild to moderate heart failure. The Dutch Ibopamine Multicenter Trial Study Group.

Brouwer J, van Veldhuisen DJ, Man in 't Veld AJ, Haaksma J, Dijk WA, Visser KR, Boomsma F, Dunselman PH.

J Am Coll Cardiol. 1996 Nov 1;28(5):1183-9.

16.

Prognostic value of the signal-averaged electrocardiogram and a prolonged QRS in ischemic and nonischemic cardiomyopathy.

Silverman ME, Pressel MD, Brackett JC, Lauria SS, Gold MR, Gottlieb SS.

Am J Cardiol. 1995 Mar 1;75(7):460-4.

PMID:
7863989
17.
18.

Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group.

Packer M, O'Connor CM, Ghali JK, Pressler ML, Carson PE, Belkin RN, Miller AB, Neuberg GW, Frid D, Wertheimer JH, Cropp AB, DeMets DL.

N Engl J Med. 1996 Oct 10;335(15):1107-14.

19.

Risk stratification in a Brazilian hospital-based cohort of 1220 outpatients with heart failure: role of Chagas' heart disease.

Freitas HF, Chizzola PR, Paes AT, Lima AC, Mansur AJ.

Int J Cardiol. 2005 Jul 10;102(2):239-47.

PMID:
15982491
20.

Predictors of all-cause mortality in chronic Chagas' heart disease in the current era of heart failure therapy.

Theodoropoulos TA, Bestetti RB, Otaviano AP, Cordeiro JA, Rodrigues VC, Silva AC.

Int J Cardiol. 2008 Aug 1;128(1):22-9. doi: 10.1016/j.ijcard.2007.11.057. Epub 2008 Feb 6.

PMID:
18258318

Supplemental Content

Support Center